Sanctuary Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Sanctuary Advisors's PFE Position: Q2 2026 in Review
Sanctuary Advisors increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $1.19M and bringing the position to 1,059,033 shares worth $25.5M. The position accounts for 0.12% of the portfolio, ranked #181.
Sanctuary Advisors first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.5M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sanctuary Advisors held 1,059,033 shares of Pfizer worth $25.5M as of Q2 2026.
- Sanctuary Advisors bought 45,358 Pfizer shares in Q2 2026, an estimated $1.19M.
- Pfizer made up 0.12% of Sanctuary Advisors's portfolio in Q2 2026, its #181 holding.
- Sanctuary Advisors first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
- Sanctuary Advisors's Pfizer position peaked at $28.5M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.